According to a new report by Polaris Market Research, the global traumatic brain injury biomarkers market was valued at USD 1.11 billion in 2024 and is projected to reach USD 6.05 billion by 2034, expanding at a CAGR of 18.5% over the forecast period. Growth is underpinned by the rising global incidence of traumatic brain injury, growing demand for rapid and objective diagnostic...